
Rethinking Pharma's Go-to-Market Formula
Mike Petroutsas, president and head of U.S. commercial at Astellas, explores the importance of insight-driven commercialization in reshaping how manufacturers engage patients, physicians and the broader healthcare ecosystem.
In this video episode of the Pharm Exec podcast, Mike Petroutsas, president and head of U.S. commercial at Astellas, shares the secrets to building a more agile commercial operating model — and mindset — equipped for today’s evolving engagement landscape.
Drawing on examples from GI oncology, retina care, and women’s health, Petroutsas joins Mike Christel, group managing editor, MJH Life Sciences, to discuss how Astellas is tapping real-world insights, social listening and internal collaboration to refine commercialization efforts and boost patient engagement.
The PhRMA board member also offers perspective on commercial strategy implications from the Inflation Reduction Act and other healthcare policy, and touches as well on the career leadership lessons that guide his approach today.
Click below to listen to the audio version and subscribe to the Pharmaceutical Executive Podcast:




